CardioGenics Holdings Company Description
CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally.
Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.
The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009.
The company was founded in 1997 and is headquartered in Mississauga, Canada.
| Country | United States |
| Founded | 1997 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Yahia Gawad |
Contact Details
Address: 6295 Northam Drive Mississauga, Nevada L4V 1W8 Canada | |
| Phone | 905-673-8501 |
| Website | cardiogenics.com |
Stock Details
| Ticker Symbol | CGNH |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | November - October |
| Reporting Currency | USD |
| ISIN Number | US14160X2036 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Dr. Yahia Abdul Gawad Ch.B., M.D., MB, MSc. | Founder, Chief Executive Officer and Director |
| James A. Essex CA, MBA | Chief Financial Officer |
| Linda J. Sterling F.Inst.L.C.O. | Corporate Secretary and Director |